Tardive Dyskinesia Market to Grow Rapidly at a CAGR of 8.1% During the Forecast Period (2026-2036) | DelveInsight

NBI-1065890BevantololPositive

AI Analysis

Summary

Market research report projects the tardive dyskinesia market will grow at a CAGR of 8.1% from 2026-2036, driven by improved diagnosis, treatment advancements, and emerging therapies including NBI-1065890 from Neurocrine Biosciences.

Importance:2/10

Sentiment:

0.30

market analysistardive dyskinesiaemerging therapiesmarket growth

Related Companies

$NBIX

Read the original article

Published by PR Newswire Biotech on July 8, 2026 2:31 PM

Read Original